Prof. Ernst Wagner is Chair of Pharmaceutical Biotechnology, Department of Pharmacy and Center of Nanoscience at LMU Munich since 2001. From 1992-2001 he was Director Cancer Vaccines, Boehringer Ingelheim (world-wide first polymer-based gene therapy trial in 1994), 1987-1995 Group Leader at IMP Vienna and Vienna University Biocenter, 1985-1987 postdoc at ETH Zurich, in 1985 PhD in chemistry (TU Vienna).

He is Academician of European Academy of Sciences, member of College of Fellows of Controlled Release Society (CRS), Board Member of German Society for Gene Therapy, Member of Nonviral Therapeutic Delivery Committee, America Society of Gene and Cell Therapy (ASGCT). He authored 513 publications, 52 296 citations, h-index 115 (GS).